Long-term Combination Therapy With α-Blockers and 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia: Patient Adherence and Causes of Withdrawal From Medication

PURPOSE: To investigate long-term therapeutic effects and patient adherence to a combination therapy of a 5α-reductase inhibitor and an α-blocker and to identify causes of withdrawal from medication in patients with clinical benign prostatic hyperplasia (BPH). METHODS: BPH patients with lower urinar...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Hueih Ling, Liao, Chun-Hou, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209571/
https://www.ncbi.nlm.nih.gov/pubmed/28043104
http://dx.doi.org/10.5213/inj.1632526.263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209571/
https://www.ncbi.nlm.nih.gov/pubmed/28043104
http://dx.doi.org/10.5213/inj.1632526.263

Ejemplares similares